127 related items for PubMed ID: 11737708
1. Failure of cortisone acetate therapy in 21-hydroxylase deficiency in early infancy.
Jinno K, Sakura N, Nomura S, Fujitaka M, Ueda K, Kihara M.
Pediatr Int; 2001 Oct; 43(5):478-82. PubMed ID: 11737708
[Abstract] [Full Text] [Related]
2. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Shibata Y.
Nihon Naibunpi Gakkai Zasshi; 1991 Aug 20; 67(8):819-39. PubMed ID: 1813324
[Abstract] [Full Text] [Related]
3. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
Cavarzere P, Samara-Boustani D, Flechtner I, Dechaux M, Elie C, Tardy V, Morel Y, Polak M.
Eur J Endocrinol; 2009 Aug 20; 161(2):285-92. PubMed ID: 19451212
[Abstract] [Full Text] [Related]
4. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
Gasparini N, Di Maio S, Salerno M, Argenziano A, Franzese A, Tenore A.
Horm Res; 1997 Aug 20; 47(1):17-22. PubMed ID: 9010713
[Abstract] [Full Text] [Related]
5. A comparison of three glucocorticoid suppressive regimes in adults with congenital adrenal hyperplasia.
Horrocks PM, London DR.
Clin Endocrinol (Oxf); 1982 Dec 20; 17(6):547-56. PubMed ID: 6299623
[Abstract] [Full Text] [Related]
6. Inappropriate adrenal androgen secretion with once-a-day corticosteroid therapy for congenital adrenal hyperplasia.
Keenan BS, Eberle AE, Lin TH, Clayton GW.
J Pediatr; 1990 Jan 20; 116(1):133-6. PubMed ID: 2153199
[Abstract] [Full Text] [Related]
7. Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11beta-hydroxysteroid dehydrogenase reductase activity.
Nordenström A, Marcus C, Axelson M, Wedell A, Ritzén EM.
J Clin Endocrinol Metab; 1999 Apr 20; 84(4):1210-3. PubMed ID: 10199755
[Abstract] [Full Text] [Related]
8. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
J Clin Endocrinol Metab; 2001 Oct 20; 86(10):4679-85. PubMed ID: 11600525
[Abstract] [Full Text] [Related]
9. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
Liu SY, Lee CT, Tung YC, Chien YH, Hwu WL, Tsai WY.
J Formos Med Assoc; 2018 Feb 20; 117(2):126-131. PubMed ID: 28392195
[Abstract] [Full Text] [Related]
10. Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia.
Melin J, Parra-Guillen ZP, Michelet R, Truong T, Huisinga W, Hartung N, Hindmarsh P, Kloft C.
J Clin Endocrinol Metab; 2020 Mar 01; 105(3):. PubMed ID: 32052005
[Abstract] [Full Text] [Related]
11. Diagnosis of adrenal cortical dysfunction by liquid chromatography-tandem mass spectrometry.
Kao PC, Machacek DA, Magera MJ, Lacey JM, Rinaldo P.
Ann Clin Lab Sci; 2001 Apr 01; 31(2):199-204. PubMed ID: 11337910
[Abstract] [Full Text] [Related]
12. A possible defect in the inter-conversion between cortisone and cortisol in prepubertal patients with congenital adrenal hyperplasia receiving cortisone acetate therapy.
Whorwood CB, Warne GL.
J Steroid Biochem Mol Biol; 1991 Oct 01; 39(4A):461-70. PubMed ID: 1911435
[Abstract] [Full Text] [Related]
13. Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing.
Janzen N, Riepe FG, Peter M, Sander S, Steuerwald U, Korsch E, Krull F, Müller HL, Heger S, Brack C, Sander J.
Horm Res Paediatr; 2012 Oct 01; 77(3):195-9. PubMed ID: 22508345
[Abstract] [Full Text] [Related]
14. Cortisol in dried blood screening specimens from newborns with raised 17-hydroxyprogesterone and congenital adrenal hyperplasia.
Mitchell ML, Hermos RJ.
Clin Endocrinol (Oxf); 1998 Jun 01; 48(6):757-60. PubMed ID: 9713565
[Abstract] [Full Text] [Related]
15. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
Feuillan P, Pang S, Schürmeyer T, Avgerinos PC, Chrousos GP.
J Clin Endocrinol Metab; 1988 Jul 01; 67(1):154-60. PubMed ID: 2837498
[Abstract] [Full Text] [Related]
16. 17-Hydroxyprogesterone in children, adolescents and adults.
Honour JW.
Ann Clin Biochem; 2014 Jul 01; 51(Pt 4):424-40. PubMed ID: 24711560
[Abstract] [Full Text] [Related]
17. Serum 17-hydroxypregnenolone and 17-hydroxypregnenolone sulfate concentrations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Shimozawa K, Saisho S, Yata J, Kambegawa A.
Endocrinol Jpn; 1988 Feb 01; 35(1):11-8. PubMed ID: 3260857
[Abstract] [Full Text] [Related]
18. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
Seppel T, Schlaghecke R.
Clin Endocrinol (Oxf); 1994 Oct 01; 41(4):445-51. PubMed ID: 7955456
[Abstract] [Full Text] [Related]
19. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
Charmandari E, Calis KA, Keil MF, Mohassel MR, Remaley A, Merke DP.
J Clin Endocrinol Metab; 2002 Jul 01; 87(7):3197-200. PubMed ID: 12107224
[Abstract] [Full Text] [Related]
20. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
Swords FM, Carroll PV, Kisalu J, Wood PJ, Taylor NF, Monson JP.
Clin Endocrinol (Oxf); 2003 Nov 01; 59(5):613-20. PubMed ID: 14616886
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
